Science

Compass pathways’ phase 2B… breakthrough therapy designation by the US FDA in late 2018… delivers mixed results

…a 35-percent response rate and a 5-percent SAE rate means for every seven patients positively responding to the treatment, one person will experience serious negative outcomes… these serious adverse events included suicidal ideation and suicidal behavior.

Five patients (6.3 percent) in the 25-mg group and six patients (8 percent) in the 10-mg group experienced at least one serious adverse event in the follow-up period after the psilocybin treatment. This compared to just one serious adverse event reported in the 1-mg placebo group.

Original Article (New Atlas):
Largest psychedelic therapy trial to date delivers mixed results
Artwork Fair Use: Beeblebrox

Science

…to define…

Spirituality

[Ergot…]

Anthropology

Hemp flowing…

Politics

…city on earth

Science

Shroom dosage…

Politics

Oregonians…

Spirituality

The future is fungi

Politics

…in Oregon

Psychology

MDMA… marriage…

Politics

…cannabis banking

Politics

…psilocybin… 

Psychology

…tripping solo

Spirituality

LSD… benefits…

Psychology

…salvinorin…

Anthropology

There will be oil

Anthropology

Cannabis goes green

Psychology

Home grow…

Psychology

…for macrodosing

Politics

First, it was weed…

Politics

Manufacturing…

Spirituality

…the Mushroom

Politics

Oregon psilocybin…

Science

What is kratom…?

Politics

SITSA … stopped

Politics

Grassy Globes